Published Date : Apr 11, 2016
E-clinical solution software products are being widely used by biotechnology, pharmaceutical, medical device, and clinical research organizations to analyze and manage clinical data. These software products are helpful in managing clinical trials due to their effectiveness over paper work. A rising number of clinical trials have augmented the growth of the global e-clinical solution market. The ClinicalTrials.gov, a service of the U.S. National Institutes of Health, lists 212,454 clinical studies presently conducted across 193 nations. The website offers a database of privately and publicly supported clinical studies of human participants conducted worldwide. The increased spending on clinical research and development in the pharmaceutical industry worldwide, along with the rising need for improved data standardization within lesser time during clinical trial process has further fuelled the demand for e-clinical solution software.
Asia Emerges as Key Destination for Pharmaceutical Firms
Asia is expected to be the fastest growing region in the global e-clinical solution software market in the near future. Owing to the rise in the research and development costs, pharmaceutical companies have shifted their focus on Asia where outsourcing key activities such as bio-statistical analysis, clinical operations, and laboratory services to clinical research organizations (CROs) has propelled the demand for e-clinical solution software. The emergence of CROs across major countries in Asia has thus boosted the regional e-clinical solution software market. In spite of challenges such as large pool of geriatric population, regulatory framework, and low awareness of enrolment opportunities, the Asia Pacific e-clinical solution software market is expected to grow significantly with China, South Korea, Taiwan, Singapore, India, Malaysia, and Australia emerging as the key clinical trial destinations.